Inhibition of Tumor Growth and Immunomodulatory Effects of Flavonoids and Scutebarbatines of Scutellaria barbata D. Don in Lewis-Bearing C57BL/6 Mice

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Gong, Tao ^a,b   Wang, Chun Fei ^b,c   Yuan, Jia Rui ^a,b   Li, Yu ^a,b   Gu, Jun Fei ^a,b   Zhao, Bing Jie ^a,b   Zhang, Li ^b,d   Jia, Xiao Bin ^a,b   Feng, Liang ^b   Liu, Shen Lin ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b KEY LABORATORY OF NEW DRUG DELIVERY SYSTEM OF CHINESE MATERIA MEDICA   (China)

^c ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

^d JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APIGENIN; AURANTIIN; FLAVONOID; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 6; LUTEOLIN; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; RETINOID X RECEPTOR GAMMA; SCUTEBARBATINE A; SCUTEBARBATINE B; SCUTELLAREIN; SCUTELLARIA BARBATA EXTRACT; SCUTELLARIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; WOGONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CANCER INHIBITION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MEGADOSE; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOMODULATION; IN VIVO STUDY; LEWIS CARCINOMA; MALE; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHIZOME; SCUTELLARIA BARBATA; TANDEM MASS SPECTROMETRY; TUMOR VOLUME; WESTERN BLOTTING;

EID: 84929996653     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/630760     Document Type: Article

References (27)

1. M. Roca, I.-C. Roca, and T. Mihəescu, "Lung cancer - a comorbidity in chronic obstructive pulmonary disease," Revista Medico-Chirurgicala a Societatii de Medici si Naturalisti din Iasi, vol. 116, no. 4, pp. 1055-1062, 2012.
2. M. Dai, Y. Y. Yip, I. Hellstrom, and K. E. Hellstrom, "Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies," Clinical Cancer Research, vol. 21, no. 5, pp. 1127-1138, 2015.
3. C. Rolfo, G. Sortino, E. Smits et al., "Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?" Expert Review of Anticancer Therapy, vol. 14, no. 10, pp. 1173-1187, 2014.
4. A. J. Furness, F. A. Vargas, K. S. Peggs, and S. A. Quezada, "Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies," Trends in Immunology, vol. 35, no. 7, pp. 290-298, 2014.
5. P. M. Forde, R. J. Kelly, and J. R. Brahmer, "New strategies in lung cancer: translating immunotherapy into clinical practice," Clinical Cancer Research, vol. 20, no. 5, pp. 1067-1073, 2014.
6. H. Xu, J. Yu, Y. Sun et al., "Scutellaria barbata D. Don extract synergizes the antitumor effects of low dose 5-fluorouracil through induction of apoptosis and metabolism," Phytomedicine, vol. 20, no. 10, pp. 897-903, 2013.
7. X. Yin, J. Zhou, Y. Zhang, D. Xing, and C. Jie, "Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549," Life Sciences, vol. 75, no. 18, pp. 2233-2244, 2004.
8. Y.-C. Yeh, H.-Y. Chen, S.-H. Yang, Y.-H. Lin, J.-H. Chiu, and J.-L. Chen, "Hedyotis diffusa combined with Scutellaria barbata are the core treatment of Chinese herbal medicine used for breast cancer patients: a population-based study," Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 202378, 9 pages, 2014.
9. L. Wei, J. Lin, W. Xu et al., "Scutellaria barbata D. Don inhibits tumor angiogenesis via suppression of hedgehog pathway in a mouse model of colorectal cancer," International Journal of Molecular Sciences, vol. 13, no. 8, pp. 9419-9430, 2012.
10. A. Shiau, Y. Shen, J. Hsieh, C. Wu, and C. Lee, "Scutellaria barbata inhibits angiogenesis through downregulation of HIF-1 a in lung tumor," Environmental Toxicology, vol. 29, no. 4, pp. 363-370, 2014.
11. P. Wang, X. Geng, G. Pi, R. Shi, Z. Yuan, and C. Wang, "Preparative separation of four individual flavonoids in Scutellaria barbata D. Don based on high selectivity polymeric adsorbents with different polarities," Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 878, no. 32, pp. 3375-3381, 2010.
12. R. Shi, S. Qiao, D. Yu et al., "Simultaneous determination of five flavonoids from Scutellaria Barbata extract in rat plasma by LC-MS/MS and its application to pharmacokinetic study," Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 879, no. 19, pp. 1625-1632, 2011.
13. Z.-J. Dai, X.-X. Liu, W. Tang et al., "Antitumor and immune-modulating effects of Scutellaria barbata extract in mice bearing hepatocarcinoma H22 cells-derived tumor," Nan Fang Yi Ke Da Xue Xue Bao, vol. 28, no. 10, pp. 1835-1837, 2008.
14. Z.-J. Dai, B.-F. Wang, W.-F. Lu et al., "Total flavonoids of Scutellaria barbata inhibit invasion of hepatocarcinoma via MMP/TIMP in vitro," Molecules, vol. 18, no. 1, pp. 934-950, 2013.
15. X. K. Yang, M. Y. Xu, G. S. Xu, Y. L. Zhang, and Z. X. Xu, "In vitro and in vivo antitumor activity of scutebarbatine A on human lung carcinoma A549 cell lines," Molecules, vol. 19, no. 7, pp. 8740-8751, 2014.
16. L. Feng, X. Jia, M.-M. Zhu, Y. Chen, and F. Shi, "Antioxidant activities of total phenols of Prunella vulgaris L. in vitro and in tumor-bearing mice," Molecules, vol. 15, no. 12, pp. 9145-9156, 2010.
17. Z.-J. Dai, W.-Y. Wu, H.-F. Kang et al., "Protective effects of Scutellaria barbata against rat liver tumorigenesis," Asian Pacific Journal of Cancer Prevention, vol. 14, no. 1, pp. 261-265, 2013.
18. L. Feng, L. Yuan, M. Du et al., "Anti-lung cancer activity through enhancement of immunomodulation and induction of cell apoptosis of total triterpenes extracted from Ganoderma luncidum (Leyss. ex Fr.) Karst," Molecules, vol. 18, no. 8, pp. 9966-9981, 2013.
19. Y. Li, J.-F. Gu, X. Zou et al., "The anti-lung cancer activities of steroidal saponins of P. polyphylla smith var. chinensis (Franch.) hara through enhanced immunostimulation in experimental lewis tumor-bearing C57BL/6 mice and induction of apoptosis in the A549 cell line," Molecules, vol. 18, no. 10, pp. 12916-12936, 2013.
20. E. Grage-Griebenow, E. Jerg, A. Gorys et al., "L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression," Molecular Oncology, vol. 8, no. 5, pp. 982-997, 2014.
21. A. Freeman, J. A. Bridge, P. Maruthayanar et al., "Comparative immune phenotypic analysis of cutaneous squamous cell carcinoma and intraepidermal carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not Foxp3+ regulatory t-cells is associated with disease stage," PLoS ONE, vol. 9, no. 10, Article ID e110928, 2014.
22. P. J. Schuler, Z. Saze, T. L. Whiteside et al., "Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells," Clinical and Experimental Immunology, vol. 177, no. 2, pp. 531-543, 2014.
23. R. Baharlou, A. A. Vasmehjani, A. Dehghani, M. A. Ghobadifar, and M. Khoubyari, "Reduced interleukin-17 and transforming growth factor Beta levels in peripheral blood as indicators for following the course of bladder cancer," Immune Network, vol. 14, no. 3, pp. 156-163, 2014.
24. S. Chatterjee, K. Thyagarajan, P. Kesarwani et al., "Reducing CD73 expression by IL1β-programmed Th17 cells improves immunotherapeutic control of tumors," Cancer Research, vol. 74, no. 21, pp. 6048-6059, 2014.
25. W. M. Braga, B. R. da Silva, A. C. de Carvalho et al., "FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4+ T regulatory cells," Cancer Immunology, Immunotherapy, vol. 63, no. 11, pp. 1189-1197, 2014.
26. S. K. Vadrevu, N. K. Chintala, S. K. Sharma et al., "Complement C5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche," Cancer Research, vol. 74, no. 13, pp. 3454-3465, 2014.
27. S. Y. Lee, K. J. Lee, J. Y. Moon et al., "Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance," Clinical and Experimental Immunology, vol. 161, no. 2, pp. 298-305, 2010.